1,179
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitors

ORCID Icon, ORCID Icon, , , , ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1483-1490 | Received 24 Mar 2020, Accepted 15 Jun 2020, Published online: 08 Jul 2020

References

  • Supuran CT, Nocentini A. Carbonic anhydrases: biochemistry and pharmacology of an evergreen pharmaceutical target. Amsterdam, Netherlands: Elsevier Science; 2019.
  • Aspatwar A, Tolvanen ME, Ortutay C, Parkkila S. Carbonic anhydrase related proteins: molecular biology and evolution. Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications. Berlin, Germany: Springer; 2014.
  • Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase i. Stop-flow kinetic studies on the native human isoenzymes b and c. J Biol Chem 1971;246:2561–73.
  • Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzym Inhib Med Chem 2016;31:345–60.
  • D’Ambrosio K, De Simone G, Supuran CT. Human carbonic anhydrases: catalytic properties, structural features, and tissue distribution. Carbonic anhydrases as biocatalysts. Amsterdam, Netherlands: Elsevier; 2015.
  • Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
  • Supuran CT, Capasso C. Acatalytic carbonic anhydrases (cas viii, x, xi). Carbonic anhydrases as biocatalysts. Amsterdam, Netherlands: Elsevier; 2015.
  • Supuran CT. Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for co2 capture. Abingdon: Taylor & Francis; 2013.
  • Carta F, Supuran CT. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005–2013). Exp Opin Ther Patent 2013;23:681–91.
  • Supuran CT, Altamimi ASA, Carta F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013–2019. Exp Opin Ther Patent 2019;29:781–92.
  • De Simone G, Supuran CT. Antiobesity carbonic anhydrase inhibitors. Curr Top Med Chem 2007;7:879–84.
  • Aggarwal M, Kondeti B, McKenna R. Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review. Exp Opin Ther Patent 2013;23:717–24.
  • Supuran CT. Carbonic anhydrase inhibition and the management of neuropathic pain. Exp Rev Neurother 2016;16:961–8.
  • Del Prete S, Vullo D, Fisher GM, et al Discovery of a new family of carbonic anhydrases in the malaria pathogen plasmodium falciparum-the η-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389–96.
  • Supuran CT. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Exp Opin Invest Drugs 2018;27:963–70.
  • Nguyen GT, Nocentini A, Angeli A, et al. Perfluoroalkyl substances of significant environmental concern can strongly inhibit human carbonic anhydrase isozymes. Anal Chem 2020;92:4614–22.
  • Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.
  • Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Exp Opin Drug Discov 2017;12:61–88.
  • Nguyen GT, Tran TN, Podgorski MN, et al Nanoscale ion emitters in native mass spectrometry for measuring Ligand-Protein Binding Affinities. ACS Central Sci 2019;5:308–18.
  • Mahon BP, McKenna R. Carbonic anhydrase iii. Carbonic anhydrases as biocatalysts. Amsterdam, Netherlands: Elsevier; 2015.
  • Ren X, Jonsson BH, Lindskog S. Some properties of site-specific mutants of human carbonic anhydrase II having active-site residues characterizing carbonic anhydrase III. Eur J Biochem 1991;201:417–20.
  • Geers C, Gros G. Effects of carbonic anhydrase inhibitors on contraction, intracellular ph and energy-rich phosphates of rat skeletal muscle. J Physiol 1990;423:279–97.
  • Räisänen SR, Lehenkari P, Tasanen M, et al. Carbonic anhydrase iii protects cells from hydrogen peroxide-induced apoptosis. FASEB J 1999;13:513–22.
  • Wroblewski K, Spalthoff S, Zimmerman UJ, et al. The role of carbonic anhydrase in the recovery of skeletal muscle from anoxia. J Appl Physiol 2005;99:488–98.
  • Staunton L, Zweyer M, Swandulla D, Ohlendieck K. Mass spectrometry-based proteomic analysis of middle-aged vs. Aged vastus lateralis reveals increased levels of carbonic anhydrase isoform 3 in senescent human skeletal muscle. Int J Mol Med 2012;30:723–33.
  • Mitterberger MC, Kim G, Rostek U, et al. Carbonic anhydrase iii regulates peroxisome proliferator-activated receptor-γ2. Exp Cell Res 2012;318:877–86.
  • Heath R, Schwartz MS, Brown IR, Carter ND. Carbonic anhydrase iii in neuromuscular disorders. J Neurol Sci 1983;59:383–8.
  • Dai HY, Hong CC, Liang SC, et al. Carbonic anhydrase iii promotes transformation and invasion capability in hepatoma cells through fak signaling pathway. Mol Carcinog 2008;47:956–63.
  • Elchuri S, Naeemuddin M, Sharpe O, et al. Identification of biomarkers associated with the development of hepatocellular carcinoma in cuzn superoxide dismutase deficient mice. Proteomics 2007;7:2121–9.
  • Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Fut Med Chem 2014;6:1149–65.
  • Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme iii with anions. J Enzym Inhib Med Chem 2009;24:70–6.
  • Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme iii with sulfonamides. Bioorg Med Chem 2007;15:7229–36.
  • Carta F, Vullo D, Osman SM, et al. Synthesis and carbonic anhydrase inhibition of a series of slc-0111 analogs. Bioorg Med Chem 2017;25:2569–76.
  • Alver A, Uçar F, Keha EE, et al. Effects of leptin and insulin on ca iii expression in rat adipose tissue. J Enzym Inhib Med Chem 2004;19:279–81.
  • Alzweiri M, Al-Balas Q, Al-Hiari Y. Chromatographic evaluation and qsar optimization for benzoic acid analogues against carbonic anhydrase iii. J Enzym Inhib Med Chem 2015;30:420–9.
  • Jarrar N, Alzweiri M, Al-Hiari Y, et al. Modified hummel-dreyer method and molecular modeling studies identified nicotinic acid analogues as carbonic anhydrase iii ligands. Lett Drug Design Discov 2016;13:401–10.
  • Alzweiri M, Al‐Hiari Y. Evaluation of vanillic acid as inhibitor of carbonic anhydrase isozyme iii by using a modified Hummel-Dreyer method: approach for drug discovery. Biomed Chromatogr 2013;27:1157–61.
  • Al-Balas Q, Anthony NG, Al-Jaidi B, et al. Identification of 2-aminothiazole-4-carboxylate derivatives active against mycobacterium tuberculosis h37rv and the β-ketoacyl-acp synthase mtfabh. PLoS One 2009;4:e5617.
  • Barton A, Breukelman SP, Kaye PT, et al. The preparation of thiazole-4-and-5-carboxylates, and an infrared study of their rotational isomers. J Chem Soc Perkin Trans 1982;1:159–64.
  • Darzens G. The general method of the synthesis of aldehydes with the help of substituted glycidic acids. Compt Rend Hebdomad Sean Acad Sci 1904;139:1214–7.
  • Berger G, Girault G. Macromolecule-ligand binding studied by the Hummel and Dreyer method: current state of the methodology. J Chromatogr B Analyt Technol Biomed Life Sci 2003;797:51–61.